• No results found

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis

N/A
N/A
Protected

Academic year: 2019

Share "Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. Patient characteristics and survival analysis according to Kaplan-Meier.
Figure 1. Overall survival of patients with loco-regional skinmetastases at the initial diagnosis of metastatic spread.Cumulative survival probabilities are stratified by the presence orabsence of additional lymph node metastases (A), the number ofaddition
Table 2. Independent prognostic factors for 377 patients with satellite or in-transit metastases according to the multivariable Coxproportional hazard analysis.

References

Related documents

that the administration of bisphosphonates including zole- dronic acid and pamidronate may provide a survival benefit in patients with metastatic breast cancer with HR-negative

Kaplan Meier survival curves according to (A) the site of distant metastasis, (B) the presence of brain metastases, (C) the LDH serum level, (D) the S100B serum level, (E) the type

Abstract: The purpose of the study was to analyze the prognostic value of metastatic lymph node ratio (LNR) in pancreatic cancer (PC) patients undergoing surgical operation..

Prognostic factors in patients with metastatic spine tumors derived from lung cancer?a novel scoring system for predicting life expectancy RESEARCH Open Access Prognostic factors

CUAJ ? Original Research Yokom et al Metastatic CRPC treated with cabazitaxel Prognostic and predictive clinical factors in patients with metastatic castration resistant prostate

In this study of patients who have undergone a margin-negative liver resection for colorectal metastases, we sought to confirm that the prognostic value of risk-scoring

In conclusion, the Breslow thickness is the most impor- tant prognostic factor for DFS and OS in Taiwanese patients with clinically node-negative cutaneous melanoma who receive

  In conclusion, for patients with CRC who receive UFT / LV adjuvant chemotherapy, three independent prognostic factors ― T4 lesions, emergency operation, and a